paid-only post

Deep Track Capital, LP

I. Basics

Deep Track Capital is a Greenwich, Connecticut-based investment firm focused exclusively on the life sciences industry. The firm develops long-term partnerships with management teams of leading innovative public and pre-IPO biotechnology companies. In addition to providing capital, it seeks to contribute time and expertise while leveraging its network for the benefit of its partners. The fund aims to lead transactions while building large syndicates and also invests in rounds led by other qualified investors.

David Kroin

David Kroin has over 25 years of healthcare investment experience. Before founding Deep Track Capital, he co-founded Great Point Partners in 2003, serving as co-portfolio manager for its biotechnology hedge fund and as an investment committee member for its private equity funds. He earned a BS in Actuarial Mathematics from the University of Michigan, where he serves on the Life Sciences Institute leadership council. David has served on various public and private healthcare company boards, including CellCarta, Cytovance, and CorEvitas. He is a husband, father of three, music enthusiast, avid traveler, storyteller, and lifelong chess player.

II. Letters & Presentations

Letters

Dynavax Technologies Corp - 19-Feb-2025| 10-Mar-2025 | 22-Apr-2025 | 12-May-2025

III. Live "significant" companies
Companies with fund stakes involved in activist actions such as 13D filing(s) or proxy campaign(s).
This post is for paying subscribers only

Subscribe to continue reading